BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 15134535)

  • 1. Retinoids in cancer chemoprevention.
    Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
    Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids in chemoprevention and differentiation therapy.
    Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
    Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
    Uray IP; Dmitrovsky E; Brown PH
    Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids and their receptors in cancer development and chemoprevention.
    Sun SY; Lotan R
    Crit Rev Oncol Hematol; 2002 Jan; 41(1):41-55. PubMed ID: 11796231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid targets in cancer therapy and chemoprevention.
    Dragnev KH; Petty WJ; Dmitrovsky E
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S150-6. PubMed ID: 14508093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
    Dawson MI; Elstner E; Kizaki M; Chen DL; Pakkala S; Kerner B; Koeffler HP
    Blood; 1994 Jul; 84(2):446-52. PubMed ID: 8025272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.